Dravid A, Betha TP, Sharma AK, Gawali R, et al. Efficacy and safety of a single-tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV-1-infected subjects on nonnucleoside reverse transcriptase inhi HIV Med 2020;21:578-587.
PMID: 33021066